Clinical Data CEO Drew Fromkin: An Interview With “The Pink Sheet” DAILY (Part 2 of 2)
This article was originally published in The Pink Sheet Daily
Executive Summary
Fromkin and Chief Medical Officer Reed talk about their targeted antidepressant vilazodone and the firm’s plans for developing other drugs with companion diagnostics.